tradingkey.logo
tradingkey.logo
Search

Aytu Biopharma Inc

AYTU
Add to Watchlist
2.230USD
+0.080+3.72%
Close 07-31 16:00ETQuotes delayed by 15 min
23.94MMarket Cap
LossP/E TTM

AYTU Financials

See Aytu Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aytu Biopharma Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.53/-0.21
Revenue / Forecast
12.41M/12.05M
Period
FY2025 Earnings
Revenue(YoY)
66.38M
-18.05%
EPS(YoY)
-2.16
24.51%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-182.09%-0.53
-920.68%-1.05
-14.32%0.21
-255.48%-2.92
224.79%0.65
422.30%0.13
116.40%0.24
-35.86%-0.82
72.99%-0.52
98.15%-0.04
-432.02%-1.48
---0.60
---1.93
---2.15
---0.28
----
----
----
----
----
Revenue
-32.74%12.41M
-6.51%15.16M
-16.21%13.89M
-15.80%15.13M
31.57%18.45M
-13.48%16.22M
-6.98%16.57M
-41.51%17.98M
-38.31%14.03M
-28.66%18.75M
-35.57%17.82M
11.96%30.73M
-6.06%22.73M
13.64%26.28M
26.30%27.66M
16.89%27.45M
79.49%24.20M
52.67%23.13M
61.96%21.90M
58.02%23.48M
Net Profit
-240.66%-5.62M
-1443.15%-10.58M
33.31%1.97M
-329.24%-19.82M
238.34%3.99M
458.18%788.00K
118.15%1.47M
-87.91%-4.62M
59.90%-2.89M
96.71%-220.00K
-1058.35%-8.12M
84.73%-2.46M
86.49%-7.20M
42.04%-6.69M
97.48%-701.00K
15.31%-16.09M
-109.31%-53.29M
-21.24%-11.55M
-546.81%-27.85M
-504.05%-19.00M
Net Margin
-311.99%-45.27%
-1802.41%-69.79%
114.55%14.15%
-411.41%-131.35%
230.89%21.35%
24.17%4.10%
115.72%6.59%
-221.26%-25.68%
48.49%-16.31%
112.96%3.30%
-1554.69%-41.94%
---7.99%
---31.67%
---25.47%
---2.53%
----
----
----
----
----
Gross Margin
-14.47%55.10%
-1.35%59.99%
-5.71%62.95%
4.54%61.67%
-4.31%64.42%
-16.68%60.82%
-1.82%66.76%
4.36%58.98%
32.55%67.32%
19.18%72.99%
11.69%67.99%
--56.52%
--50.79%
--61.25%
--60.88%
----
----
----
----
----
Debt to assets ratio
13.26%19.53%
25.79%17.16%
52.12%21.74%
37.13%17.57%
32.95%17.25%
11.58%13.64%
17.84%14.29%
6.85%12.81%
-23.90%12.97%
-21.60%12.22%
-19.39%12.13%
--11.99%
--17.05%
--15.59%
--15.05%
----
----
----
----
----
Revenue
-32.74%12.41M
-6.51%15.16M
-16.21%13.89M
-15.80%15.13M
31.57%18.45M
-13.48%16.22M
-6.98%16.57M
-41.51%17.98M
-38.31%14.03M
-28.66%18.75M
-35.57%17.82M
11.96%30.73M
-6.06%22.73M
13.64%26.28M
26.30%27.66M
16.89%27.45M
79.49%24.20M
52.67%23.13M
61.96%21.90M
58.02%23.48M
Operating profit
-267.86%-4.06M
-421.16%-1.97M
-930.14%-1.50M
141.86%640.00K
278.94%2.42M
-112.02%-378.00K
83.16%-146.00K
-154.43%-1.53M
85.44%-1.35M
175.03%3.15M
47.55%-867.00K
139.54%2.81M
1.77%-9.29M
62.87%-4.19M
79.95%-1.65M
36.38%-7.10M
51.02%-9.46M
-102.58%-11.29M
-131.84%-8.25M
-73.41%-11.17M
Net Profit
-240.66%-5.62M
-1443.15%-10.58M
33.31%1.97M
-329.24%-19.82M
238.34%3.99M
458.18%788.00K
118.15%1.47M
-87.91%-4.62M
59.90%-2.89M
96.71%-220.00K
-1058.35%-8.12M
84.73%-2.46M
86.49%-7.20M
42.04%-6.69M
97.48%-701.00K
15.31%-16.09M
-109.31%-53.29M
-21.24%-11.55M
-546.81%-27.85M
-504.05%-19.00M
Current assets
-7.15%67.33M
20.92%76.24M
33.54%81.11M
27.93%79.18M
1.94%72.51M
-11.65%63.05M
-13.97%60.74M
-15.02%61.89M
-9.35%71.13M
1.08%71.37M
-5.13%70.60M
21.53%72.83M
0.66%78.47M
-19.34%70.61M
-16.42%74.42M
-43.05%59.93M
-22.06%77.95M
-5.40%87.54M
36.03%89.04M
39.53%105.23M
Total current liabilities
-15.18%59.97M
2.37%65.56M
7.74%65.99M
1.34%63.06M
-15.51%70.71M
-0.22%64.05M
-6.43%61.25M
-9.83%62.23M
-2.02%83.69M
-4.41%64.19M
-10.57%65.46M
7.10%69.02M
6.29%85.42M
-33.23%67.15M
-25.30%73.20M
-41.12%64.44M
-3.97%80.36M
289.61%100.57M
355.67%98.00M
280.48%109.44M
Total assets
-10.07%111.69M
4.97%122.00M
7.91%124.99M
5.15%124.18M
-3.62%124.20M
-11.45%116.23M
-12.84%115.83M
-13.46%118.09M
-12.47%128.86M
-7.20%131.25M
-11.41%132.89M
-0.84%136.46M
-12.80%147.22M
-36.81%141.44M
-34.13%150.00M
-48.20%137.62M
-37.83%168.83M
34.23%223.82M
61.20%227.73M
73.31%265.67M
Total liabilities
-14.29%76.55M
26.14%107.80M
18.38%101.82M
16.41%105.21M
-8.95%89.30M
-13.14%85.46M
-14.61%86.00M
-6.93%90.38M
-7.73%98.09M
2.90%98.40M
4.82%100.72M
6.09%97.11M
-1.28%106.30M
-19.16%95.62M
-17.32%96.09M
-28.55%91.53M
-16.14%107.68M
118.85%118.29M
131.50%116.23M
119.81%128.10M
Total equity
0.70%35.14M
-53.84%14.20M
-22.31%23.17M
-31.57%18.97M
13.39%34.90M
-6.36%30.77M
-7.28%29.83M
-29.58%27.72M
-24.77%30.78M
-28.30%32.85M
-40.33%32.17M
-14.61%39.36M
-33.09%40.91M
-56.59%45.82M
-51.65%53.91M
-66.50%46.09M
-57.29%61.14M
-6.35%105.54M
22.44%111.50M
44.79%137.57M
Net operating income
35.21%-4.18M
26.51%3.67M
48.07%-618.00K
455.71%2.80M
-2441.34%-6.46M
2251.85%2.91M
-463.98%-1.19M
-108.41%-788.00K
91.26%-254.00K
94.47%-135.00K
97.69%-211.00K
231.99%9.37M
68.12%-2.91M
72.34%-2.44M
-141.31%-9.15M
-12.87%-7.09M
-3.84%-9.12M
-201.57%-8.82M
52.51%-3.79M
19.04%-6.29M
Net investment
100.00%0.00
-111.72%-17.00K
-100.00%0.00
-8773.53%-3.02M
-53.33%-69.00K
183.33%145.00K
601.32%381.00K
78.06%-34.00K
-4600.00%-45.00K
-3380.00%-174.00K
-280.95%-76.00K
-278.05%-155.00K
101.43%1.00K
99.84%-5.00K
148.84%42.00K
98.30%-41.00K
77.95%-70.00K
-10157.88%-3.05M
-855.56%-86.00K
-5268.35%-2.42M
Net financing
-79.72%872.00K
-126.92%-6.26M
152.03%2.30M
1116.57%12.99M
711.13%4.30M
-2090.48%-2.76M
133.32%911.00K
119.76%1.07M
-79.48%530.00K
93.24%-126.00K
-120.17%-2.73M
-383.80%-5.40M
69.82%2.58M
-128.30%-1.86M
348.11%13.56M
-109.45%-1.12M
123.77%1.52M
-75.66%6.59M
-150.87%-5.46M
285.40%11.82M

FAQs

What is the total revenue of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its total revenue reached 66.38M, with a year-on-year change of 81.00M.

What are the current assets of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its current assets were 79.18M, with a year-on-year change of 27.93.

What are the total assets of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its total assets of Aytu Biopharma Inc were 124.18M, with a year-on-year change of 5.15.

What are the total liabilities of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its total liabilities of Aytu Biopharma Inc were 105.21M, with a year-on-year change of 16.41.

What is the total equity of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its total equity of Aytu Biopharma Inc was 18.97M, with a year-on-year change of -31.57.

What is the net operating income of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its net operating income of Aytu Biopharma Inc was 2.54M, with a year-on-year change of 187.82.

What is the net investment of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its net investment of Aytu Biopharma Inc was -2.56M, with a year-on-year change of -678.12.

What is the net financing of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its net financing of Aytu Biopharma Inc was 15.44M, with a year-on-year change of 1323.69.

What is the Earnings Per Share (EPS) of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.16, with a year-on-year change of 24.51.

What is the net income of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its net income was -13.56M, with a year-on-year change of 14.40.

What is the net margin of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its net profit margin was -21.36, with a year-on-year change of -9.22.

What is the gross margin of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its gross margin was 63.49, with a year-on-year change of 4.17.

What is the debt-to-asset ratio of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its debt-to-asset ratio was 17.57, with a year-on-year change of 37.13.

What is the Return on Equity (ROE) of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -60.76, with a year-on-year change of -28.61.

What is the Return on Assets (ROA) of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -11.71, with a year-on-year change of 5.95.

What is the operating profit of Aytu Biopharma Inc?

According to Aytu Biopharma Inc's FY2025 earnings report, its operating profit was 2.54M, with a year-on-year change of 187.82.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.